They’re often called the four “pillars” of cancer treatment because of their prevalence. Physicians have used surgery, chemotherapy, radiation therapy,...
Now that the Centers for Medicare & Medicaid Services (CMS) has lowered the boom on payers by dropping the star...
This white paper highlights 5 pressing challenges payers face as they attempt to enable the best outcomes for their members,...
The idea of value-based care has been around since the late 1960s, when the American Academy of Pediatrics first introduced...
As the biopharmaceutical industry evolves rapidly, biosimilar products are reshaping the autoimmune treatment paradigm. This comprehensive eBook explores the role...
Radiation therapy (RT) is one of several treatment types for cancer in both curative and palliative settings. It is used...
As a payer, you are challenged to keep costs low while enabling appropriate care for your members. Eviti Connect is...
NantHealth explores the impact of new biosimilar drugs for autoimmune treatment. We will discuss how payers can prepare for the...
According to a study published in The Commonweath Fund Issue Brief titled U.S. Health Care from a Global Perspective, 2022:...
HITRUST Certification validates NantHealth’s commitment to aligning with key regulations and protecting sensitive information MORRISVILLE, N.C. – March 21, 2023 — NantHealth,...
If a recent LinkedIn poll is any indication, managing high drug costs associated with cancer care continues to be a...
Value-Based Healthcare and Evidence-Based Treatment Rank Highest Recently, we conducted a new survey on our LinkedIn asking respondents the question,...